These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 25601454)

  • 1. Tolerance of benznidazole in a United States Chagas Disease clinic.
    Miller DA; Hernandez S; Rodriguez De Armas L; Eells SJ; Traina MM; Miller LG; Meymandi SK
    Clin Infect Dis; 2015 Apr; 60(8):1237-40. PubMed ID: 25601454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arthritis and benznidazole: more closely related than we thought.
    Aldasoro E; Pinazo MJ; Oliveira I; Munoz J; Posada E; Requena-Méndez A; Serret N; Gascon J
    Antimicrob Agents Chemother; 2015 Jan; 59(1):727-9. PubMed ID: 25385100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerance of benznidazole in treatment of Chagas' disease in adults.
    Pinazo MJ; Muñoz J; Posada E; López-Chejade P; Gállego M; Ayala E; del Cacho E; Soy D; Gascon J
    Antimicrob Agents Chemother; 2010 Nov; 54(11):4896-9. PubMed ID: 20823286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High frequency of adverse reactions and discontinuation with benznidazole treatment for chronic Chagas disease in Milan, Italy.
    Antinori S; Grande R; Bianco R; Traversi L; Cogliati C; Torzillo D; Repetto E; Corbellino M; Milazzo L; Galli M; Galimberti L
    Clin Infect Dis; 2015 Jun; 60(12):1873-5. PubMed ID: 25805302
    [No Abstract]   [Full Text] [Related]  

  • 5. Adverse systemic reaction to benznidazole.
    Coronel MV; Frutos LO; Muñoz EC; Valle DK; Rojas DH
    Rev Soc Bras Med Trop; 2017; 50(1):145-147. PubMed ID: 28327820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low Incidence of Adverse Effects Using a Progressive Regimen of Benznidazole in Chagas Disease.
    Navarrete MN; Gutiérrez-Gutiérrez B; de Arellano-Ramos R; Del Castillo SF; Domínguez-Castellano Á
    Clin Infect Dis; 2016 Apr; 62(8):1052. PubMed ID: 26769725
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the toxicity of two treatment schemes with benznidazole for chronic Chagas disease: a prospective cohort study in two Spanish referral centres.
    Crespillo-Andújar C; López-Vélez R; Trigo E; Norman F; Díaz-Menéndez M; Monge-Maillo B; Arsuaga M; Pérez-Molina JA
    Clin Microbiol Infect; 2020 Mar; 26(3):384.e1-384.e4. PubMed ID: 31740423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Side effects of benznidazole treatment in a cohort of patients with Chagas disease in non-endemic country.
    Carrilero B; Murcia L; Martínez-Lage L; Segovia M
    Rev Esp Quimioter; 2011 Sep; 24(3):123-6. PubMed ID: 21947093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of adverse reactions to benznidazole in patients with Chagas disease in the Federal District, Brazil.
    Gontijo MKCL; Arruda HMBDS; Noronha EF; Toledo MI
    Rev Soc Bras Med Trop; 2020; 53():e20190150. PubMed ID: 31994658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What to expect and when: benznidazole toxicity in chronic Chagas' disease treatment.
    Aldasoro E; Posada E; Requena-Méndez A; Calvo-Cano A; Serret N; Casellas A; Sanz S; Soy D; Pinazo MJ; Gascon J
    J Antimicrob Chemother; 2018 Apr; 73(4):1060-1067. PubMed ID: 29351667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nifurtimox therapy for Chagas disease does not cause hypersensitivity reactions in patients with such previous adverse reactions during benznidazole treatment.
    Pérez-Molina JA; Sojo-Dorado J; Norman F; Monge-Maillo B; Díaz-Menéndez M; Albajar-Viñas P; López-Vélez R
    Acta Trop; 2013 Aug; 127(2):101-4. PubMed ID: 23583863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should benznidazole be used in chronic Chagas' disease?
    Bestetti RB
    Lancet; 1997 Mar; 349(9052):653. PubMed ID: 9057760
    [No Abstract]   [Full Text] [Related]  

  • 13. Adverse events after the use of benznidazole in infants and children with Chagas disease.
    Altcheh J; Moscatelli G; Moroni S; Garcia-Bournissen F; Freilij H
    Pediatrics; 2011 Jan; 127(1):e212-8. PubMed ID: 21173000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities.
    Viotti R; Vigliano C; Lococo B; Alvarez MG; Petti M; Bertocchi G; Armenti A
    Expert Rev Anti Infect Ther; 2009 Mar; 7(2):157-63. PubMed ID: 19254164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart rate variability in chronic Chagas patients before and after treatment with benznidazole.
    Oliveira LF; Silva VJ; Lages-Silva E; Molina RJ; Fuzissaki J; Niederhaur S; Prata A; Correia D
    Auton Neurosci; 2010 Dec; 158(1-2):118-22. PubMed ID: 20558113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinical adverse drug reaction prediction model for patients with chagas disease treated with benznidazole.
    Sperandio da Silva GM; Mediano MF; Alvarenga Americano do Brasil PE; da Costa Chambela M; da Silva JA; de Sousa AS; Xavier SS; Rodrigues da Costa A; Magalhães Saraiva R; Hasslocher-Moreno AM
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6371-7. PubMed ID: 25114135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of cytokine profile and HLA association in benznidazole related cutaneous reactions in patients with Chagas disease.
    Salvador F; Sánchez-Montalvá A; Martínez-Gallo M; Sala-Cunill A; Viñas L; García-Prat M; Aparicio G; Sao Avilés A; Artaza MÁ; Ferrer B; Molina I
    Clin Infect Dis; 2015 Dec; 61(11):1688-94. PubMed ID: 26265500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trial of posaconazole and benznidazole for chronic Chagas' disease.
    Molina I; Gómez i Prat J; Salvador F; Treviño B; Sulleiro E; Serre N; Pou D; Roure S; Cabezos J; Valerio L; Blanco-Grau A; Sánchez-Montalvá A; Vidal X; Pahissa A
    N Engl J Med; 2014 May; 370(20):1899-908. PubMed ID: 24827034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seronegative conversion after incomplete benznidazole treatment in chronic Chagas disease.
    Alvarez MG; Vigliano C; Lococo B; Petti M; Bertocchi G; Viotti R
    Trans R Soc Trop Med Hyg; 2012 Oct; 106(10):636-8. PubMed ID: 22898619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reply to Antinori et al.
    Miller DA; Traina MM; Meymandi SK
    Clin Infect Dis; 2015 Jun; 60(12):1875-6. PubMed ID: 25805304
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.